You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Dopamine Uptake Inhibitors

Showing 1 - 25 of 7,705
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Depression, MDD, Dysthymic Disorder Trial in Indianapolis (behavioral, drug, other)

Completed
Has Results
  • Depression
  • +7 more
  • Beating the Blues (BtB)
  • +3 more
  • Indianapolis, Indiana
    IUPUI Department of Psychology
Aug 30, 2021

Parkinson Disease Trial in Lund, Cambridge (STEM-PD)

Recruiting
  • Parkinson Disease
  • STEM-PD
  • Lund, Sweden
  • +1 more
Dec 7, 2022

Pathological Gambling Trial (Tolcapone, Placebo)

Completed
Has Results
  • Pathological Gambling
  • (no location specified)
Feb 10, 2021

Cocaine-Related Disorders Trial in New Haven (Bupropion)

Terminated
  • Cocaine-Related Disorders
  • New Haven, Connecticut
    VA Connecticut Healthcare System
Jun 17, 2020

Parkinsonian Syndrome, Parkinson Disease(PD), Multiple System Atrophy (MSA) Trial in China (DaTSCAN™ Ioflupane (123I) Injection)

Completed
  • Parkinsonian Syndrome
  • +3 more
  • DaTSCAN™ Ioflupane (123I) Injection
  • Beijing, Chaoyang District, China
  • +9 more
Jun 20, 2022

Methamphetamine Use Disorder Trial in Lexington (Methamphetamine, Methylphenidate, Placebo oral capsule)

Completed
  • Methamphetamine Use Disorder
  • Lexington, Kentucky
  • +1 more
Jan 14, 2022

Non Small Cell Lung Cancer Trial in Brussels (FAPI PET/CT)

Recruiting
  • Non Small Cell Lung Cancer
  • FAPI PET/CT
  • Brussels, Belgium
    Institut Jules Bordet
Oct 24, 2023

Parkinson's Disease, Pain Trial in Toulouse (ioflupane 123I (DATSCAN®))

Completed
  • Parkinson's Disease
  • Pain
  • ioflupane 123I (DATSCAN®)
  • Toulouse, France
    University Hospital Toulouse
Jul 28, 2020

DaTSCAN Brain Scintigraphy and Psychotropic Treatments:

Not yet recruiting
  • Parkinson Disease
  • scintigraphy DaTSCAN
  • Vandœuvre-lès-Nancy, France
    CHRU Nancy
Jan 5, 2023

Type2 Diabetes, Heart Failure With Preserved Ejection Fraction Trial in San Antonio (Empagliflozin 25 MG, Placebo)

Recruiting
  • Type2 Diabetes
  • Heart Failure With Preserved Ejection Fraction
  • Empagliflozin 25 MG
  • Placebo
  • San Antonio, Texas
  • +1 more
Jan 21, 2023

D3 Dopamine Receptor, Cocaine-dependent, Healthy Volunteer Trial in Philadelphia ([18F]FTP PET/CT)

Active, not recruiting
  • D3 Dopamine Receptor
  • +2 more
  • [18F]FTP PET/CT
  • Philadelphia, Pennsylvania
    University of Pennsylvania
Jul 5, 2022

Parkinson Disease Trial in Seoul (A9-DPC)

Recruiting
  • Parkinson Disease
  • Seoul, Korea, Republic of
    Yonsei University Health System, Severance Hospital
May 24, 2023

Parkinson Disease, Treatment Adherence Trial in Ankara (Levodopa)

Enrolling by invitation
  • Parkinson Disease
  • Treatment Adherence
  • Ankara, Turkey
    Ankara Atatürk Sanatorium Training and Research Hospital
Oct 30, 2023

PET Scanning in Parkinson s Disease

Recruiting
  • Schizophrenia
  • Parkinson's Disease
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 25, 2023

Qualitative Features of Atherosclerotic Plaques

Active, not recruiting
  • Atherosclerotic Cardiovascular Disease
  • Riga, Latvia
    Pauls Stradins Clinical University Hospital
Dec 5, 2022

Idiopathic Parkinson's Progression and Dopamine Transporter

Completed
  • Parkinson Disease
  • Ioflupane I 123
  • Lexington, Kentucky
    University of Kentucky Department of Neurology
Nov 16, 2022

Cocaine Use Disorder Trial in Pittsburgh (Baseline [C-11]NPA PET Scan, d-amphetamine, Post-amphetamine [C-11]NPA PET Scan)

Recruiting
  • Cocaine Use Disorder
  • Baseline [C-11]NPA PET Scan
  • +2 more
  • Pittsburgh, Pennsylvania
    University of PIttsburgh
Jun 27, 2022

Healthy Trial in Zürich (Psilocybin, 3,4 Methylenedioxymethamphetamine, Methylphenidate)

Recruiting
  • Healthy
  • Zürich, Switzerland
    Psychiatrische Universitätsklinik Zürich
Oct 3, 2023

Advanced Parkinson's Disease Trial in Orange, New York, Toronto (MSK-DA01, MSK-DA01 Cell Delivery Device)

Active, not recruiting
  • Advanced Parkinson's Disease
  • MSK-DA01
  • MSK-DA01 Cell Delivery Device
  • Orange, California
  • +2 more
May 31, 2022

Chronic Anergic-anhedonic Depression Open Trial

Recruiting
  • Depressive Disorder, Treatment-Resistant
    • Strasbourg, France
      CENTRE DE NEUROMODULATION NON INVASIVE DE STRASBOURG (CEMNIS) -
    Oct 25, 2023

    Immunomodulatory Effects of PCSK9 Inhibition

    Not yet recruiting
    • Atherosclerotic Cardiovascular Disease
    • +3 more
    • Contrast-enhanced CCTA
    • 99mTc-tilmanocept SPECT/CT scanning
    • Boston, Massachusetts
      Massachusetts General Hospital
    Jan 30, 2023

    NSCLC, Immunotherapy Trial in Ann Arbor (Dexamthasone)

    Terminated
    • Non-Small Cell Lung Cancer
    • Immunotherapy
    • Ann Arbor, Michigan
      VA Ann Arbor Healthcare System, Ann Arbor, MI
    Jan 6, 2023

    Parkinson Disease, Idiopathic Parkinson Disease Trial in Philadelphia (Intravenous and Oral n-acetyl cysteine)

    Active, not recruiting
    • Parkinson Disease
    • Idiopathic Parkinson Disease
    • Intravenous and Oral n-acetyl cysteine
    • Philadelphia, Pennsylvania
      Thomas Jefferson University
    Jul 11, 2022

    Castration-Resistant Prostate Carcinoma, Metastatic Prostate Carcinoma, Stage IV Prostate Cancer American Joint Committee on

    Terminated
    • Castration-Resistant Prostate Carcinoma
    • +4 more
    • Computed Tomography
    • +2 more
    • Los Angeles, California
      UCLA / Jonsson Comprehensive Cancer Center
    Sep 19, 2022

    Parkinson Disease Trial in Paris (Identification of COMT HH, COMT HL or COMT LL genes, Brain MRI with resting state scan, Brain

    Completed
    • Parkinson Disease
    • Identification of COMT HH, COMT HL or COMT LL genes
    • +2 more
    • Paris, France
      Groupe Hospitalier Pitié-Salpêtrière
    Feb 17, 2022